These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 7923174
1. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells. Strickland DK, Vaidyanathan G, Zalutsky MR. Cancer Res; 1994 Oct 15; 54(20):5414-9. PubMed ID: 7923174 [Abstract] [Full Text] [Related]
2. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines. Strickland DK, Vaidyanathan G, Friedman HS, Zalutsky MR. J Neurooncol; 1995 Oct 15; 25(1):9-17. PubMed ID: 8523094 [Abstract] [Full Text] [Related]
3. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. Vaidyanathan G, Zhao XG, Larsen RH, Zalutsky MR. Br J Cancer; 1997 Oct 15; 76(2):226-33. PubMed ID: 9231923 [Abstract] [Full Text] [Related]
4. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO. Bruchelt G, Girgert R, Buck J, Wolburg H, Niethammer D, Treuner J. Cancer Res; 1988 Jun 01; 48(11):2993-7. PubMed ID: 3365688 [Abstract] [Full Text] [Related]
5. Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent. Vaidyanathan G, Strickland DK, Zalutsky MR. Int J Cancer; 1994 Jun 15; 57(6):908-13. PubMed ID: 8206683 [Abstract] [Full Text] [Related]
6. Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma. Batra V, Samanta M, Makvandi M, Groff D, Martorano P, Elias J, Ranieri P, Tsang M, Hou C, Li Y, Pawel B, Martinez D, Vaidyanathan G, Carlin S, Pryma DA, Maris JM. Clin Cancer Res; 2022 Sep 15; 28(18):4146-4157. PubMed ID: 35861867 [Abstract] [Full Text] [Related]
7. Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model. Vaidyanathan G, Friedman HS, Keir ST, Zalutsky MR. Nucl Med Biol; 1996 Aug 15; 23(6):851-6. PubMed ID: 8940730 [Abstract] [Full Text] [Related]
8. Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions. Cunningham SH, Mairs RJ, Wheldon TE, Welsh PC, Vaidyanathan G, Zalutsky MR. Br J Cancer; 1998 Jun 15; 77(12):2061-8. PubMed ID: 9649115 [Abstract] [Full Text] [Related]
9. Radiation quality-dependent bystander effects elicited by targeted radionuclides. Boyd M, Sorensen A, McCluskey AG, Mairs RJ. J Pharm Pharmacol; 2008 Aug 15; 60(8):951-8. PubMed ID: 18644188 [Abstract] [Full Text] [Related]
10. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Smets LA, Loesberg C, Janssen M, Metwally EA, Huiskamp R. Cancer Res; 1989 Jun 01; 49(11):2941-4. PubMed ID: 2720653 [Abstract] [Full Text] [Related]
11. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D. Cancer Res; 1985 Dec 01; 45(12 Pt 1):6366-70. PubMed ID: 3864530 [Abstract] [Full Text] [Related]
12. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes. Weber W, Weber J, Senekowitsch-Schmidtke R. Cancer Res; 1996 Dec 01; 56(23):5428-34. PubMed ID: 8968097 [Abstract] [Full Text] [Related]
13. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells. Iavarone A, Lasorella A, Servidei T, Riccardi R, Troncone L, Mastrangelo R. J Nucl Biol Med (1991); 1991 Dec 01; 35(4):186-90. PubMed ID: 1823815 [Abstract] [Full Text] [Related]
14. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Voigt A, Zintl F. Med Pediatr Oncol; 2003 Apr 01; 40(4):205-13. PubMed ID: 12555246 [Abstract] [Full Text] [Related]
15. In vitro and in vivo studies with no-carrier added radioiodinated MIBG. Franceschini R, Pecorale A, Chinol M, Calcagni ML, Servidei T, Riccardi R, Troncone L. Q J Nucl Med; 1995 Dec 01; 39(4 Suppl 1):72-7. PubMed ID: 9002755 [Abstract] [Full Text] [Related]
16. Hyperbaric oxygen enhances the effects of meta-iodobenzylguanidine (MIBG) on energy metabolism and lipid peroxidation in the human neuroblastoma cell line SK-N-BE(2C). Cornelissen J, Van Kuilenburg AB, Elzinga L, Van der Kleij AD, Voûte PA, Van Gennip AH. Anticancer Res; 1997 Dec 01; 17(1A):259-64. PubMed ID: 9066662 [Abstract] [Full Text] [Related]
17. Evaluation of pharmacokinetics, safety, and efficacy of [211At] meta-astatobenzylguanidine ([211At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol. Kobayakawa M, Shiga T, Takahashi K, Sugawara S, Nomura K, Hanada K, Ishizuka N, Ito H. PLoS One; 2024 Dec 01; 19(5):e0303623. PubMed ID: 38805424 [Abstract] [Full Text] [Related]
18. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells. Montaldo PG, Carbone R, Lanciotti M, Ponzoni M, Cornaglia-Ferraris P. J Nucl Biol Med (1991); 1991 Dec 01; 35(4):195-8. PubMed ID: 1823817 [Abstract] [Full Text] [Related]
19. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms. Montaldo PG, Lanciotti M, Casalaro A, Cornaglia-Ferraris P, Ponzoni M. Cancer Res; 1991 Aug 15; 51(16):4342-6. PubMed ID: 1868458 [Abstract] [Full Text] [Related]
20. Differential drug sensitivity of human neuroblastoma cells. Spengler BA, Ross RA, Biedler JL. Cancer Treat Rep; 1986 Aug 15; 70(8):959-65. PubMed ID: 3731152 [Abstract] [Full Text] [Related] Page: [Next] [New Search]